相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HIV Type 1 Antiretroviral Resistance Mutations in Subtypes B, C, and F in the City of Sao Paulo, Brazil
Patricia Munerato et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2010)
Enfuvirtide (T-20) Resistance-Related Mutations in HIV Type 1 Subtypes B, C, and F Isolates from Brazilian Patients Failing HAART
A. C. A. Oliveira et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Adherence to enfuvirtide and its impact on treatment efficacy
Juergen Rockstroh et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
Selective regimes and evolutionary rates of HIV-1 subtype B V3 variants in the Brazilian epidemic
Ricardo Sobhie Diaz et al.
VIROLOGY (2008)
MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0
Koichiro Tamura et al.
MOLECULAR BIOLOGY AND EVOLUTION (2007)
Increased polymorphism in the HR-1 gp41 env gene encoding the enfuvirtide (T-20) target in HIV-1 variants harboring multiple antiretroviral drug resistance mutations in the pol gene
Ali Si-Mohamed et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Rapid emergence of enfuvirtide resistance in HIV-1-infected patients: Results of a clonal analysis
Jing Lu et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Long-term monitoring of genotypic and phenotypic resistance to T20 in treated patients infected with HIV-1
L Pérez-Alvarez et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: A Danish, population-based, 6-year follow-up study
N Lohse et al.
CLINICAL INFECTIOUS DISEASES (2006)
Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients
M Zaccarelli et al.
AIDS (2005)
Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41
L Xu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Analysis of full-length human immunodeficiency virus type 1 genome reveals a variable spectrum of subtypes B and F recombinants in Sao Paulo, Brazil
DJ De Sa et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2005)
HIV-1 drug resistance evolution among patients on potent combination antiretroviral therapy with detectable viremia
S Napravnik et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates
PR Sista et al.
AIDS (2004)
Genotype and phenotype patterns of human immunodeficiency virus type 1 resistance to enfuvirtide during long-term treatment
S Menzo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Long-term follow-up of HIV-infected individuals who have significant increases in CD4+ cell counts during antiretroviral therapy
SL Koletar et al.
CLINICAL INFECTIOUS DISEASES (2004)
Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America
JP Lalezari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia
A Lazzarin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia
SG Deeks et al.
AIDS (2002)
分享论文
